Radiation-induced alterations in rat mesangial cell Tgfb1 and Tgfb3 gene expression are not associated with altered secretion of active Tgfb isoforms

Radiation Research

Volumn 152, Issue 6, 1999, Pages 622-628

  O'Malley, Yunxia ^a   Zhao, Weiling ^a   Barcellos Hoff, Mary Helen ^b   Robbins, Mike E C ^a  

^a UNIVERSITY OF IOWA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CESIUM 137; COMPLEMENTARY DNA; CYTOKINE; GENE PRODUCT; MESSENGER RNA; NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GAMMA RADIATION; GENE EXPRESSION; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RADIATION DOSE; RADIATION INJURY; RAT;

EID: 0032779115     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3580257     Document Type: Article

References (39)

1. M. B. Sporn and A. B. Roberts, TGF-β: Problems and prospects. Cell. Regul. 1, 875-882 (1990).
2. J. Massague, The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6, 597-641 (1990).
3. A. B. Roberts, S. J. Kim, T. Noma, A. B. Glick, R. Lafyatis, R. Lechleider, S. B. Jakowlew, A. Geiser, M. A. O'Reilly and M. B. Sporn. Multiple forms of TGF-β: distinct promoters and differential expression. In Clinical Applications of TGF-β (M. B. Sporn and A. B. Roberts, Eds.), pp. 7-28. Wiley, Chichester, 1991.
4. R. A. Ignotz and J. Massague, Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261, 4337-4345 (1986).
5. A. Bassols and J. Massague, Transforming growth factor β regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans. J. Biol. Chem. 263, 3039-3045 (1988).
6. A. P. Kuravilla, R. Shah, G. M. Hochwald, H. D. Liggitt, M. A. Palladino and G. J. Thorbecke, Protective effect of transforming growth factor β1 on experimental autoimmune diseases in mice. Proc. Natl. Acad. Sci. USA 88, 2918-2921 (1991).
7. D. R. Edwards, G. Murphy, J. J. Reynolds, S. E. Whitham, A. J. P. Docherty, P. Angel and J. K. Heath, Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6, 1899-1904 (1987).
8. M. Laiho, O. Sakesala and J. Keski-Oja, Transforming growth factor-β induction of type-1 plasminogen activator inhibitor. J. Biol. Chem. 262, 17467-17474 (1987).
9. R. A. Ignotz and J. Massague, Cell adhesion protein receptors as targets for transforming growth factor-β action. Cell 51, 189-197 (1987).
10. A. B. Roberts, B. K. McCune and M. B. Sporn, TGF-β: Regulation of extracellular matrix. Kidney Int. 41, 557-559 (1992).
11. W. A. Border and N. A. Noble, Transforming growth factor β in tissue fibrosis. N. Engl. J. Med. 331, 1286-1292 (1994).
12. P. A. Canney and S. Dean, Transforming growth factor beta: A promoter of late connective tissue following radiotherapy? Br. J. Radiol. 63, 620-623 (1990).
13. K. K. Richter, C-C. Sung, C. W. Langberg and M. Hauer-Jensen, Association of transforming growth factor β (TGF-β) immunoreactivity with specific histopathologic lesions in subacute and chronic experimental radiation enteropathy. Radiother. Oncol 39, 243-251 (1996).
14. M. Martin, J. L. Lefaix, P. Pinton, F. Crechet and F. Daburon, Temporal modulation of TGF-β1 and β-actin gene expression in pig skin and muscular fibrosis after ionizing radiation. Radiat. Res. 134, 63-70 (1993).
15. J. N. Finkelstein, C. J. Johnston, R. Baggs and P. Rubin, Early alterations in extracellular matrix and transforming growth factor β gene expression in mouse lung indicative of late radiation fibrosis. Int. J. Radiat. Oncol. Biol. Phys. 28, 621-631 (1994).
16. M. S. Anscher, I. R. Crocker and R. L. Jirtle, Transforming growth factor-β1 expression in irradiated liver. Radiat. Res. 122, 77-85 (1990).
17. J. Wang and M. E. C. Robbins, Radiation-induced alteration of rat mesangial cell transforming growth factor-β and expression of the genes associated with the extracellular matrix. Radiat. Res. 146, 561-568 (1996).
18. D. S. Romeo, K. Park, A. B. Roberts, M. B. Sporn and S. J. Kim, An element of the transforming growth factor-β1 5′-untranslated region represses translation and specifically binds a cytosolic factor. Mol. Endocrinol. 7, 759-766 (1993).
19. R. Derynck, P. B. Lindquist, A. Lee, D. Wen, J. Tamm, J. L. Graycar, L. Rhee, A. J. Mason, D. A. Miller and E. Y. Chen, A new type of transforming growth factor-β, TGF-β3. EMBO J. 7, 3737-3743 (1988).
20. K. Miyazono, U. Hellman, C. Wernstedt and C. H. Heldin, Latent high molecular weight complex of transforming growth factor β1: Purification from human platelets and structural characterization. J. Biol. Chem. 263, 6407-6415 (1988).
21. L. M. Wakefield, D. M. Smith, K. C. Flanders and M. B. Sporn, Latent transforming growth factor-β from human platelets: A high molecular weight complex containing precursor sequences. J. Biol. Chem. 263, 7646-7654 (1988).
22. M. Abe, J. G. Harpel, C. N. Metz, I. Nunes, D. J. Loskutoff and D. B. Rifkin, An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem. 216, 276-284 (1994).
23. S. Kaname, S. Uchida, E. Ogata and Y. Kurokawa, Autocrine secretion of transforming growth factor-β in cultured rat mesangial cells. Kidney Int. 42, 1319-1327 (1992).
24. J. L. Cone, D. R. Brown and J. E. DeLarco, Improved method of purification of transforming growth factor, type β from platelets. Anal. Biochem. 168, 71-74 (1988).
25. S. Kagami, W. A. Border, D. A. Miller and N. A. Noble, Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat mesangial cells. J. Clin. Invest. 93, 2431-2437 (1994).
26. B. L. Riser, P. Cortes, C. Heilig, J. Grondin, S. Ladson-Wofford, D. Patterson and R. G. Nairns, Cyclic stretching force selectively up-regulates transforming growth factor-β isoforms in cultured rat mesangial cells. Am. J. Pathol. 148, 1915-1923 (1996).
27. N. L. Thompson, K. C. Flanders, J. M. Smith, L. R. Ellingsworth, A. B. Roberts and M. B. Sporn, Expression of transforming growth factor-β1 in specific cells and tissues of adult and neonatal mice. J. Cell Biol. 108, 661-669 (1989).
28. K. Sharma and F. N. Ziyadeh, The emerging role of transforming growth factor-β in kidney diseases. Am. J. Physiol. 266, F829-F842 (1994).
29. K. Krieglstein and K. Unsicker, Bovine chromaffin cells release a transforming growth factor-β-like molecule contained within chromaffin granules. J. Neurochem. 65, 1423-1426 (1995).
30. M. A. van Waarde, A. J. van Assen, H. H. Kampinga, A. W. T. Konings and Z. Vujaskovic, Quantification of transforming growth factor-beta in biological material using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem. 247, 45-51 (1997)
31. J. L. Graycar, D. A. Miller, B. A. Arrick, R. M. Lyons, H. L. Moses and R. Derynck, Human transforming growth factor-beta 3: recombinant expression, purification and biological activities in comparison with transforming growth factors beta 1 and beta 2. Mol. Endocrinol. 3, 1977-1986 (1989).
32. 3 and their receptors are differentially regulated during normal and impaired wound healing. J. Biol. Chem. 271, 10188-10193 (1996).
33. N. Sanderson, V. Factor, P. Nagy, J. Kopp, P. Kondaiah, L. Wakefield, A. B. Roberts and M. B. Sporn, Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc. Natl. Acad. Sci. USA 92, 2572-2576 (1995).
34. M. Shah, D. M. Foreman and M. W. Ferguson, Neutralization of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J. Cell Sci. 108, 985-1002 (1995).
35. S. J. Shankland, J. Pippin, R. H. Pichler, K. L. Gordon, S. Friedman, L. I. Gold, R. J. Johnson and W. G. Couser, Differential expression of transforming growth factor-β isoforms and receptors in experimental membranous nephropathy. Kidney Int. 50, 116-124 (1996).
36. T. Oikawa, M. Freeman, W. Lo, D. E. Vaughan and A. Fogo, Modulation of plasminogen activator inhibitor-1 in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. Kidney Int. 51, 164-172 (1997).
37. 1, J. Am. Soc. Nephrol. 8, 526A (1997). [Abstract]
38. M. H. Barcellos-Hoff, Latency and activation in the control of TGF-β. J. Mammary Gland Biol. Neoplasia 1, 353-363 (1996).
39. W. Zhao, Y. O'Malley and M. E. C. Robbins, Irradiation of rat mesangial cells alters the expression of gene products associated with the development of renal fibrosis. Radial. Res. 152, 160-169 (1999).